Reports on NIDA’s research priorities—drug abuse and addiction prevention, treatment, and HIV/AIDS—which will remain consistent during these challenging budget times.
NIDA Director Dr. Nora D. Volkow summarizes instances where discoveries with broad implications for human health arose from scientists seeking answers to addiction problems.
Commemorates NIDA’s 35th anniversary and highlights some of the major accomplishments since the Institute’s inception in 1974.
Describes an NIH-wide obesity task force and research plan and explores some of the links between addiction and compulsive eating.
Highlights NIDA-funded research to develop vaccines against addiction to drugs such as cocaine, nicotine, phencyclidine (PCP), and methamphetamine.
Reports on research investigating whether certain medications might strengthen patients' understanding and memory retention.
Describes a knowledge- and resource-sharing system for NIH-funded neuroscientists to access to data, advanced research tools, and technical assistance.
Explores research findings on the value of motivational incentives to promote and reinforce abstinence from substances of abuse and encourage healthy behaviors.
Describes a toolkit that guides doctors in assessing a patient’s risk of developing an addiction problem, advising patients on the effects of substance abuse, and arranging for referrals.
Reports on the research underway to identify gene variations associated with nicotine addiction and the interaction of genetic makeup, experiences, and surroundings to addiction.